# Effect of GLP-1 on Postprandial Lipid Metabolism

> **NCT01760772** · NA · UNKNOWN · sponsor: **David Dalessio** · enrollment: 42 (estimated)

## Conditions studied

- Heart Disease

## Interventions

- **DRUG:** Exendin-9
- **DRUG:** GLP-1
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT01760772
- **Lead sponsor:** David Dalessio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760772, "Effect of GLP-1 on Postprandial Lipid Metabolism". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01760772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*